{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T07:08:58Z","timestamp":1763017738305},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,5,15]]},"DOI":"10.1093\/cid\/cix116","type":"journal-article","created":{"date-parts":[[2017,2,15]],"date-time":"2017-02-15T11:47:53Z","timestamp":1487159273000},"page":"1326-1327","source":"Crossref","is-referenced-by-count":10,"title":["Next Generation Inactivated Poliovirus Vaccine: The Future Has Arrived"],"prefix":"10.1093","volume":"64","author":[{"given":"Roland W.","family":"Sutter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiro","family":"Okayasu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Paule","family":"Kieny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,2,14]]},"reference":[{"key":"key\n\t\t\t\t20170502004238_CIT0001","volume-title":"WHO Global Action Plan to minimize poliovirus facility-associated risk after type-specific eradication of wild polioviruses and sequential cessation of oral polio vaccine","author":"Polio Eradication Department","year":"2015"},{"key":"key\n\t\t\t\t20170502004238_CIT0002","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/434699a","article-title":"A global call for new polio vaccines","volume":"434","year":"2005","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170502004238_CIT0003","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1097\/00006454-198811000-00003","article-title":"Sabin inactivated trivalent poliovirus vaccine: first clinical trial and seroimmunity survey","volume":"7","year":"1988","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20170502004238_CIT0004","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/infdis\/jit155","article-title":"Phase II and III clinical studies of diphtheria-tetanus-acellular pertussis vaccine containing inactivated polio vaccine derived from Sabin strains (DTaP-sIPV)","volume":"208","year":"2013","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170502004238_CIT0005","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1093\/cid\/cix110","article-title":"Immune serum from Sabin- inactivated poliovirus vaccine immunization neutralizes multiple individual wild and vaccine-derived polioviruses","volume":"64","year":"2017","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170502004238_CIT0006","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.biologicals.2016.08.005","article-title":"Development of inactivated poliovirus vaccine from Sabin strains: A progress report","volume":"44","year":"2016","journal-title":"Biologicals"},{"key":"key\n\t\t\t\t20170502004238_CIT0007","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1086\/424524","article-title":"Evaluation of immunogenicity and protective properties of inactivated poliovirus vaccines: a new surrogate method for predicting vaccine efficacy","volume":"190","year":"2004","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170502004238_CIT0008","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1093\/infdis\/jiw433","article-title":"Phase 3 trial of a Sabin strain-based inactivated poliovirus vaccine","volume":"214","year":"2016","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170502004238_CIT0009","doi-asserted-by":"crossref","first-page":"4938","DOI":"10.1016\/j.vaccine.2014.07.029","article-title":"Safety and immunogenicity of a primary series of Sabin-IPV with and without aluminum hydroxide in infants","volume":"32","year":"2014","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170502004238_CIT0010","first-page":"561","article-title":"Meeting of the Strategic Advisory Group of Expert on immunization, October 2016\u2014conclusions and recommendations","volume":"91","author":"World Health Organization","year":"2016","journal-title":"Wkly Epidemiol Rec"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/64\/10\/1326\/17827766\/cix116.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T19:00:59Z","timestamp":1503601259000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article-lookup\/doi\/10.1093\/cid\/cix116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,14]]},"references-count":10,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2017,2,14]]},"published-print":{"date-parts":[[2017,5,15]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/cix116","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,14]]}}}